The manufacturer became aware of a study from (b)(6) hospital, (b)(6).The study was published on 5 may 2011, within that publication, 14 cases involving supracondylar femoral nail(scn) & t2 tibial nail were reported, which were found to be off-label.The study states, ¿to overcome these problems and improve outcomes, certain modifications to the standard operative technique have been proposed, such as the use of blocking screws, additional buttress plate, different patient positioning, and extended parapatellar or retro patellar approaches.According to this guideline, the entry portal of the nail on the coronal level must be lateral or medial, depending on the side where the fracture approximates most the articular surface of the proximal tibia on the anteroposterior (ap) view.¿ it was not possible to ascertain specific device or patient information from the report, a review of the complaint handling database, however, revealed that the events have not been reported previously, therefore 14 complaints were initiated retrospectively for the off-label use mentioned in the report.This product inquiry addresses the excessive varus/ revision nailing.The report states, ¿there was also a case (case 11) where the preoperative assessment led to a wrong decision for the entry portal location, leading to unacceptable fracture alignment (158 of varus deformity).The patient was re-operated few days later when a new mid-line entry portal changed the trajectory of the nail and resulted in the restoration of leg alignment.¿.
|